Ovarian Cancer Research Funding Opportunity FY 2026 Award Cycle (University of Colorado Cancer Center) — Collaborative Pilot Grants

Ovarian Cancer Research Funding Opportunity FY 2026 Award Cycle (University of Colorado Cancer Center) — Collaborative Pilot Grants

Due Date: 03/31/2026

The University of Colorado Cancer Center is offering internal funding to support innovative ovarian cancer research enabled through philanthropic support. The RFA is intended to stimulate impactful translational, clinical, or basic science projects that advance understanding, treatment, or prevention of ovarian cancer. Collaborative Pilot Grants are designed to stimulate multi‑investigator work likely to lead to a multi‑PI NIH or other national grant submission within ~15–18 months. Projects are reviewed using an NIH‑style peer review process.

Eligibility Criteria:

  • Must involve two or more co‑PIs, with at least one Cancer Center member.
  • Cancer Center membership is required to submit under this RFA (membership is voluntary, but required for submission).
  • Only one proposal per contact/lead PI.

Funding Details: 

  • Up to $100,000 requested (issued for a 24‑month period).
  • Budgets $75,000–$100,000 anticipated; higher with justification may be considered.
  • No indirect costs funded.
  • Funds may not be used for faculty salaries or equipment.

Deadline:

  • Proposal deadline: March 31, 2026 (5:00 pm MST/MT).
  • Study section review: May 14, 2026.
  • Anticipated award start date: July 1, 2026.

Where to go for further information: